Expression of two 50 kDa proteins is associated with sensitivity towards etherlipid analogues in the human leukaemia cell line HL 60

European Journal of Cancer

Volumn 33, Issue 11, 1997, Pages 1875-1880

  Berkovic, D ^a   Hiddemann, W ^a   Kuduz, J ^a   Fleer, E A M ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Alkylphosphocholines; Etherlipids; Hexadecylphosphocholine; Mechanism of action; Resistance to etherlipids

Indexed keywords

CD15 ANTIGEN; CD33 ANTIGEN; CELL PROTEIN; ETHER LIPID; ETHER PHOSPHOLIPID; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; ILMOFOSINE; MICROSOMAL AMINOPEPTIDASE; MILTEFOSINE;

ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER RESISTANCE; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; DRUG RESISTANCE, NEOPLASM; HL-60 CELLS; HUMANS; NEOPLASM PROTEINS; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE;

EID: 0031424203     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00234-7     Document Type: Article

References (42)

1. Fleer AM, Kim DJ, Nagel GA, Eidl H, Unger C. Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells. Onkologie 1990, 13, 295-300.
2. Unger C. Alkylphosphocholine und Analoga. Entwicklung einer neuen Substanzgruppe mit antineoplastischer Wirkung. Thieme, Stuttgart, 1989, 1-106.
3. Hilgard P, Stekar J, Voegeli R, et al. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506). EurJ Clin Oncol 1988, 24, 1457-1467.
4. Unger C, Damenz W, Fleer EAM, et cd. Hexadecylphosphocholine, a new etherlipid analogue: Studies on the antineoplastic activity in vitro and in vivo. Acta Oncol 1989, 28, 213-217.
5. Scherf HR, Schuler B, Berger MR, Schmähl D. Therapeutic activity of hexadecylphosphocholine against mammary tumors in BD-VI rats. Lipids 1987, 22, 927-929.
6. Eibl H, Unger C. Hexadecylphosphocholine: a new selective antitumor drug. Cancer Treatment Rev 1990, 17, 233-242.
7. Hilgard P, Harleman JH, Voegeli R, Maurer HR, Echarti C, Unger C. The antineoplastic activity of hexadecylphosphocholine is associated with rumor cell differentiation. Proc Am Assoc Cancer Res 1989, 30, 3210.
8. Hochhuth C, Berkovic D, Eibl H, Unger C, Doenecke D. Effects of neoplastic phospholipids on parameters of cell differentiation in U 937 cells. J Cancer Res Clin Oncol 1990, 116, 459-4166.
9. Schallier DC, Bruyneel EA, Storme GA, Hugard P, Marcel MM. Antiinvasive activity of hexadecylphosphocholine in vitro. Anticancer Res 1991, 11, 1285-1292.
10. Zheng B, Oishi K, Shoji M, et al. Inhibition of protein kinase C (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues. Cancer Res 1990, 50, 3025-3031.
11. 3 and BM 41.440. Biochem BiophysRes Commun 1988, 157, 1000-1006.
12. Shoji M, Raynor RL, Berdel WE, Vogler WR, Kuo JF. Effects of thioether phospholipid BM 41.440 on protein kinase C and phorbol ester-induced differentiation on human leukemia HL 60 and KG-1 cells. Cancer Res 1988, 48, 6669-6673.
13. Kramer IM, van der Bend RL, Tool ATJ, van Blitterswijk WJ, Roos D, Verhoeven AJ. l-O-Hexadecyl-2-O-methylglycerol, a novel inhibitor of protein kinase C, inhibits respiratory burst in human neutrophils. J Biol Chem 1989, 264, 5876-5884.
14. Shoji M, Raynor RL, Fleer EAM, Eibl H, Vogler WR, Kuo JF. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL 60 cells. Lipids 1991, 26, 145-149.
15. Salari H, Dryden P, Davenport R, Howard S, Jones K, Bittman R. Inhibition of protein kinase C by ether-linked lipids is not correlated with their antineoplastic activity on WEHI-3B and R6X-B15 cells. Biochim Biophys Acta 1992, 1134, 81-88.
16. Berkovic D, Berkovic K, Fleer EAM, Eibl H, Unger C. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and l-Ooctadecyl-2-O-methyl-rac-glycero-3phosphocholine do not correlate with inhibition of proliferation of HL 60 and K 562 cell lines. Eur y Cancer 1994, 30A, 509-515.
17. Heesbeen EC, Verdonck LF, Staal GEJ, Rijksen G. Protein kinase C is not involved in the cytotoxic action of 1-O-octadecyl2-O-methyl-s-glycero-3-phosphocholine in HL 60 and K 562 cells. Biochem Pharmacol 1994, 47, 1481-1488.
18. Herrmann DBJ. Changes in cellular lipid synthesis of normal and neoplastic cells during cytolysis induced by alkyl lysophospholipid analogues. J Nad Cancer Inst 1985, 75, 219-222.
19. Vogler WR, Whigham E, Bennett WD, Olson AC. Effect of alkyllysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines. Exp Hematol 1985, 13, 629-633.
20. Modollel M, Andreesen R, Pahlke W, Brugger U, Munder PG. Disturbance of phospholipid metabolism during selective destruction of tumor cells induced by alkyllysophospholipid. Cancer Res 1985, 39, 4681-41686.
21. Berkovic D, Grunwald U, Menzel W, Unger C, Hiddemann W, Fleer EAM. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells. Eur J Cancer 1995, 31A, 2080-2085.
22. Geilen CG, Wieder T, Reutter W. Hexadecylphosphocholine inhibits translation of CTPxholinephosphate-cytidylyltransferase in Madin-Darby canine kidney cells. J Biol Chem 1992, 267, 6719-6724.
23. 3 does not correlate with the relative effects of the alkyllysophospholipid on the incorporation of fatty acids into cellular phospholipids. Cancer Res 1992, 52, 2813-2817.
24. Lu X, Arthur G. Perturbations of cellular acylation processes by the synthetic alkyllysophospholipid l-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF 7 and T 84 cell lines. Cancer Res 1992, 52, 2806-2812.
25. Seewald MJ, Olsen RA, Sehgal J, Milder DC, Modest EJ, Powis G. Inhibition of growth factor-dependent inositol phosphate Ca2signalling by antitumour ether lipid analogues. Cancer Res 1990, 50, 4458-4463.
26. Powis G, Seewald MJ, Gratas C, Müder DC, Riebow J, Modest EJ. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 1992, 52, 2835-2840.
27. Bergren MI, Gallegos A, Dressier LA, Modest EJ, Powis G. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res 1993, 53, 4297-4302.
28. Überall F, Oberhuber H, Maly K, Zaknum J, Demuth L, Grunicke HH. Hexadecylphosphocholine inhibits inositol phosphate formation and protein kinase C activity. Cancer Res 1991, 51, 807-812.
29. Kosano H, Takatani O. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. Cancer Res 1988, 49, 2868-2870.
30. Kosano H, Takatani O. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth (EGF) in human breast cancer cell lines in relation to EGF intenalization. Cancer Res 1989, 49, 2868-2870.
31. Shoji M, Fukuhara T, Winton EF, Berdel WE, Vogler WR. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony stimulating factor binding to human leukemic cell lines. Exp Hemawl 1994, 22, 13-18.
32. Fleer EAM, Berkovic D, Grunwald U, Hiddemann W. Induction of resistance to hexadecylphosphocholine in the highly sensitive human epidermoid tumour cell line KB. Eur J Cancer 1996, 32A, 506-511.
33. Berkovic D, Haase D, Hiddemann W, Fleer EAM. Induction of resistance in the human leukemia cell line HL 60 towards hexadecylphosphocholine and other etherphospholipid analogues. J Exp Ther Oncol 1996, 1, 368-376.
34. Vallari DS, Smith ZL, Snyder F. HL 60 cells become resistant towards antitumor ether-linked phospholipids following differentiation into a granulocytic form. Biochem Biophys Res Commun 1988, 156, 1-8.
35. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37, 911-917.
36. Eibl H, Lands WEM. A new sensitive determination of phosphate. Anal Biochem 1969, 30, 51-57.
37. Omodeo-Sale F, Marchesini S, Fishman PH, Berra B. A sensitive enzymatic assay for the determination of cholesterol in lipid extracts. Anal Biochem 1984, 145, 347-350.
38. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 1977, 83, 346-356.
39. Bazill GW, Dexter TM. Role of endocytosis in the action of ether lipids on WEHI-3B, HL 60, and FDCP-mix cells. Cancer Res 1990, 50, 7505-7512.
40. Fleer EAM, Berkovic D, Eibl H, Unger C. Investigations on the cellular uptake of hexadecylphosphocholine. Lipids 1993, 28, 731-736.
41. Diomede L, Bizzi A, Magistrelli A, Modest EJ, Salmona M, Noseda A. Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity. Int J Cancer 1990, 46, 341-346.
42. Chabot MC, Wykle RL, Modest EJ, Daniel LW. Correlation of ether lipid content of human cell lines and their susceptibility to l-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Cancer Res 1989, 49, 4441-4445.